Carregant...
Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
Myasthenia gravis (MG) is the most common autoimmune disorder affecting the neuromuscular junction, characterized by skeletal muscle weakness and fatigability. It is caused by autoantibodies targeting proteins of the neuromuscular junction; ~85% of MG patients have autoantibodies against the muscle...
Guardat en:
| Publicat a: | Front Neurol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7734299/ https://ncbi.nlm.nih.gov/pubmed/33329350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.596981 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|